BACKGROUND: TNF-alpha and IL-1 have been associated with mucosal inflammation in both Crohn's disease (CD) and ulcerative colitis (UC). Innate immune defects have been associated with CD, specifically CARD15/NOD2. Recently, Toll-like receptor 8 (TLR8) signaling has been shown to enhance generation of both cytokines. Interestingly, TLR8 is located on the X chromosome and inflammatory bowel disease (IBD) has been associated with abnormalities of the X chromosome. The aim was to test whether TLR8 haplotypes are associated with IBD. METHODS: Subjects (735 CD, 343 UC, 245 controls) were genotyped. Single nucleotide polymorphisms (SNPs) were chosen to tag common Caucasian haplotypes. RESULTS: Both "risk (H4)" and "protective (H1)" TLR8 haplotypes were observed associated with CD in females. Eighteen percent of CD females had H4 compared with 9% of controls (P = 0.02). Fifty-nine percent of CD females had H1 compared with 72% of controls (P = 0.01). H1 was also negatively associated with UC in females (59% of UC, 72% of controls P = 0.03). Diplotype analysis of CD, UC, and all IBD in females revealed that 2 protective haplotypes (H1/H1) had a markedly diminished odds ratio, 0.4-0.5. The presence of a risk haplotype (H4 / not H1) had a significantly increased odds ratio, 2.0-2.2. Thus, the risk for IBD was 4-5 times higher in females with 1 risk haplotype than with the protective/protective diplotype. CONCLUSIONS: TLR8 is an X-linked IBD susceptibility gene with both common predisposing and protecting haplotypes. These associations further emphasize the importance of genetic variation in innate immunity as determinants, not only of CD, but of UC as well.
BACKGROUND:TNF-alpha and IL-1 have been associated with mucosal inflammation in both Crohn's disease (CD) and ulcerative colitis (UC). Innate immune defects have been associated with CD, specifically CARD15/NOD2. Recently, Toll-like receptor 8 (TLR8) signaling has been shown to enhance generation of both cytokines. Interestingly, TLR8 is located on the X chromosome and inflammatory bowel disease (IBD) has been associated with abnormalities of the X chromosome. The aim was to test whether TLR8 haplotypes are associated with IBD. METHODS: Subjects (735 CD, 343 UC, 245 controls) were genotyped. Single nucleotide polymorphisms (SNPs) were chosen to tag common Caucasian haplotypes. RESULTS: Both "risk (H4)" and "protective (H1)" TLR8 haplotypes were observed associated with CD in females. Eighteen percent of CD females had H4 compared with 9% of controls (P = 0.02). Fifty-nine percent of CD females had H1 compared with 72% of controls (P = 0.01). H1 was also negatively associated with UC in females (59% of UC, 72% of controls P = 0.03). Diplotype analysis of CD, UC, and all IBD in females revealed that 2 protective haplotypes (H1/H1) had a markedly diminished odds ratio, 0.4-0.5. The presence of a risk haplotype (H4 / not H1) had a significantly increased odds ratio, 2.0-2.2. Thus, the risk for IBD was 4-5 times higher in females with 1 risk haplotype than with the protective/protective diplotype. CONCLUSIONS:TLR8 is an X-linked IBD susceptibility gene with both common predisposing and protecting haplotypes. These associations further emphasize the importance of genetic variation in innate immunity as determinants, not only of CD, but of UC as well.
Authors: Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler Journal: Nat Genet Date: 2005-10-23 Impact factor: 38.330
Authors: Richard Shen; Jian-Bing Fan; Derek Campbell; Weihua Chang; Jing Chen; Dennis Doucet; Jo Yeakley; Marina Bibikova; Eliza Wickham Garcia; Celeste McBride; Frank Steemers; Francisco Garcia; Bahram G Kermani; Kevin Gunderson; Arnold Oliphant Journal: Mutat Res Date: 2005-06-03 Impact factor: 2.433
Authors: Jian-Bing Fan; Kevin L Gunderson; Marina Bibikova; Joanne M Yeakley; Jing Chen; Eliza Wickham Garcia; Lori L Lebruska; Marc Laurent; Richard Shen; David Barker Journal: Methods Enzymol Date: 2006 Impact factor: 1.600
Authors: Shane M Devlin; Huiying Yang; Andrew Ippoliti; Kent D Taylor; Carol J Landers; Xiaowen Su; Maria T Abreu; Konstantinos A Papadakis; Eric A Vasiliauskas; Gil Y Melmed; Phillip R Fleshner; Ling Mei; Jerome I Rotter; Stephan R Targan Journal: Gastroenterology Date: 2006-11-10 Impact factor: 22.682
Authors: Keith B Gorden; Kevin S Gorski; Sheila J Gibson; Ross M Kedl; William C Kieper; Xiaohong Qiu; Mark A Tomai; Sefik S Alkan; John P Vasilakos Journal: J Immunol Date: 2005-02-01 Impact factor: 5.422
Authors: Masayuki Saruta; Kathrin S Michelsen; Lisa S Thomas; Qi T Yu; Carol J Landers; Stephan R Targan Journal: Eur J Immunol Date: 2009-08 Impact factor: 5.532
Authors: Dermot P B McGovern; Michelle R Jones; Kent D Taylor; Kristin Marciante; Xiaofei Yan; Marla Dubinsky; Andy Ippoliti; Eric Vasiliauskas; Dror Berel; Carrie Derkowski; Deb Dutridge; Phil Fleshner; David Q Shih; Gil Melmed; Emebet Mengesha; Lily King; Sheila Pressman; Talin Haritunians; Xiuqing Guo; Stephan R Targan; Jerome I Rotter Journal: Hum Mol Genet Date: 2010-06-22 Impact factor: 6.150
Authors: Theresa T Pizarro; Luca Pastorelli; Giorgos Bamias; Rekha R Garg; Brian K Reuter; Joseph R Mercado; Marcello Chieppa; Kristen O Arseneau; Klaus Ley; Fabio Cominelli Journal: Inflamm Bowel Dis Date: 2011-05-06 Impact factor: 5.325
Authors: Nathalie de Sena Pereira; Tamyres Bernadete Dantas Queiroga; Daniela Ferreira Nunes; Cléber de Mesquita Andrade; Manuela Sales Lima Nascimento; Maria Adelaide Do-Valle-Matta; Antônia Cláudia Jácome da Câmara; Lúcia Maria da Cunha Galvão; Paulo Marcos Matta Guedes; Egler Chiari Journal: PLoS Negl Trop Dis Date: 2018-07-25